[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL", "age": 58, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 3332915, "exercisedValue": 0, "unexercisedValue": 3757481}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2936973, "exercisedValue": 0, "unexercisedValue": 520353}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 55, "title": "Chief Operating Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 706970, "exercisedValue": 0, "unexercisedValue": 4750777}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 57, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 34, "title": "Chief Business Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 72, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Karas", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 618614, "exercisedValue": 0, "unexercisedValue": 4320554}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1751328000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.92, "open": 17.87, "dayLow": 17.41, "dayHigh": 18.05, "regularMarketPreviousClose": 17.92, "regularMarketOpen": 17.87, "regularMarketDayLow": 17.41, "regularMarketDayHigh": 18.05, "payoutRatio": 0.0, "beta": 0.97, "forwardPE": -23.513159, "volume": 2694366, "regularMarketVolume": 2694366, "averageVolume": 1404804, "averageVolume10days": 1257200, "averageDailyVolume10Day": 1257200, "bid": 17.83, "ask": 17.93, "bidSize": 3, "askSize": 5, "marketCap": 1755077120, "fiftyTwoWeekLow": 8.906, "fiftyTwoWeekHigh": 18.9, "priceToSalesTrailing12Months": 18.07085, "fiftyDayAverage": 15.9103, "twoHundredDayAverage": 13.85775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1548805376, "profitMargins": -0.16114001, "floatShares": 53634426, "sharesOutstanding": 98213600, "sharesShort": 14864141, "sharesShortPriorMonth": 16577058, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1513, "heldPercentInsiders": 0.16935, "heldPercentInstitutions": 0.7911, "shortRatio": 9.08, "shortPercentOfFloat": 0.2476, "impliedSharesOutstanding": 98213600, "bookValue": 2.333, "priceToBook": 7.659666, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -15650000, "trailingEps": -0.16, "forwardEps": -0.76, "enterpriseToRevenue": 15.947, "enterpriseToEbitda": -57.964, "52WeekChange": 0.63047445, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 17.87, "targetHighPrice": 40.0, "targetLowPrice": 28.0, "targetMeanPrice": 32.0, "targetMedianPrice": 30.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 275727008, "totalCashPerShare": 2.807, "ebitda": -26720000, "totalDebt": 69456000, "quickRatio": 10.354, "currentRatio": 11.001, "totalRevenue": 97122000, "debtToEquity": 30.334, "revenuePerShare": 0.998, "returnOnAssets": -0.06097, "returnOnEquity": -0.069120005, "grossProfits": 77753000, "freeCashflow": -9596500, "operatingCashflow": -20484000, "grossMargins": 0.80057, "ebitdaMargins": -0.27512, "operatingMargins": -4.66286, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "regularMarketChangePercent": -0.2790136, "regularMarketPrice": 17.87, "corporateActions": [], "postMarketTime": 1753484664, "regularMarketTime": 1753473601, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": 1.95858, "postMarketPrice": 18.22, "postMarketChange": 0.349998, "regularMarketChange": -0.049999237, "regularMarketDayRange": "17.41 - 18.05", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1404804, "fiftyTwoWeekLowChange": 8.964001, "fiftyTwoWeekLowChangePercent": 1.0065125, "fiftyTwoWeekRange": "8.906 - 18.9", "fiftyTwoWeekHighChange": -1.0299988, "fiftyTwoWeekHighChangePercent": -0.05449729, "fiftyTwoWeekChangePercent": 63.047443, "earningsTimestamp": 1747220400, "earningsTimestampStart": 1754305140, "earningsTimestampEnd": 1754654400, "earningsCallTimestampStart": 1747225800, "earningsCallTimestampEnd": 1747225800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.16, "epsForward": -0.76, "epsCurrentYear": -1.545, "priceEpsCurrentYear": -11.566344, "fiftyDayAverageChange": 1.9597006, "fiftyDayAverageChangePercent": 0.123171814, "twoHundredDayAverageChange": 4.012251, "twoHundredDayAverageChangePercent": 0.2895312, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2025-07-25", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]